Lioresal Stungulyf/innrennslislyf, lausn 0,5 mg/ml Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

lioresal stungulyf/innrennslislyf, lausn 0,5 mg/ml

novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 0,5 mg/ml

Lioresal Stungulyf/innrennslislyf, lausn 2 mg/ml Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

lioresal stungulyf/innrennslislyf, lausn 2 mg/ml

novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 2 mg/ml

Lioresal Stungulyf/innrennslislyf, lausn 50 míkróg/ml Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

lioresal stungulyf/innrennslislyf, lausn 50 míkróg/ml

novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 50 míkróg/ml

Sandomigrin Húðuð tafla 0,5 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

sandomigrin húðuð tafla 0,5 mg

ethyx pharmaceuticals - pizotifenum maleat - húðuð tafla - 0,5 mg

Tegretol Mixtúra, dreifa 20 mg/ml Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

tegretol mixtúra, dreifa 20 mg/ml

novartis healthcare a/s - carbamazepinum inn - mixtúra, dreifa - 20 mg/ml

Tegretol Tafla 200 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

tegretol tafla 200 mg

novartis healthcare a/s - carbamazepinum inn - tafla - 200 mg

Tegretol Retard Forðatafla 200 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

tegretol retard forðatafla 200 mg

novartis healthcare a/s - carbamazepinum inn - forðatafla - 200 mg

Tegretol Retard Forðatafla 400 mg Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

tegretol retard forðatafla 400 mg

novartis healthcare a/s - carbamazepinum inn - forðatafla - 400 mg

Tevimbra Union européenne - islandais - EMA (European Medicines Agency)

tevimbra

novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - Æxlishemjandi lyf - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.

Aclasta Union européenne - islandais - EMA (European Medicines Agency)

aclasta

sandoz pharmaceuticals d.d. - zoledronsýra - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - lyf til að meðhöndla beinsjúkdóma - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture, including those with a recent low-trauma hip fracture. meðferð beinbrot í tengslum við langtíma almenn sykurstera meðferð í tíðahvörf konur og menn á jókst hættan á beinbrot. meðferð gerðar voru á fyrirbyggjandi er sjúkdómur bein.